# Novartis AG: Form 6-K, filed Jun 11, 2026

- Company: [Novartis AG](/companies/nvs.md) (CIK 1114448)
- Form: 6-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 07:58 ET
- Period: 2026-06-11
- Accession: 0001171843-26-004052
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1114448/000117184326004052/f6k_061126.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114448/000117184326004052/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114448/000117184326004052/f6k_061126.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-004052. Last ingested by Listed: Nov 10, 2026, 04:31 ET. No prices; not investment advice.
